209 related articles for article (PubMed ID: 8670238)
1. Second zinc finger mutants of thyroid hormone receptor selectively preserve DNA binding and heterodimerization but eliminate transcriptional activation.
Nagaya T; Kopp P; Kitajima K; Jameson JL; Seo H
Biochem Biophys Res Commun; 1996 May; 222(2):524-30. PubMed ID: 8670238
[TBL] [Abstract][Full Text] [Related]
2. Interaction of human beta 1 thyroid hormone receptor and its mutants with DNA and retinoid X receptor beta. T3 response element-dependent dominant negative potency.
Meier CA; Parkison C; Chen A; Ashizawa K; Meier-Heusler SC; Muchmore P; Cheng SY; Weintraub BD
J Clin Invest; 1993 Oct; 92(4):1986-93. PubMed ID: 8408652
[TBL] [Abstract][Full Text] [Related]
3. The function of retinoid X receptors on negative thyroid hormone response elements.
Takeda T; Nagasawa T; Miyamoto T; Hashizume K; DeGroot LJ
Mol Cell Endocrinol; 1997 Apr; 128(1-2):85-96. PubMed ID: 9140079
[TBL] [Abstract][Full Text] [Related]
4. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers.
Vivat V; Zechel C; Wurtz JM; Bourguet W; Kagechika H; Umemiya H; Shudo K; Moras D; Gronemeyer H; Chambon P
EMBO J; 1997 Sep; 16(18):5697-709. PubMed ID: 9312028
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D receptor displays DNA binding and transactivation as a heterodimer with the retinoid X receptor, but not with the thyroid hormone receptor.
Thompson PD; Hsieh JC; Whitfield GK; Haussler CA; Jurutka PW; Galligan MA; Tillman JB; Spindler SR; Haussler MR
J Cell Biochem; 1999 Dec; 75(3):462-80. PubMed ID: 10536369
[TBL] [Abstract][Full Text] [Related]
6. Determinants of chromatin disruption and transcriptional regulation instigated by the thyroid hormone receptor: hormone-regulated chromatin disruption is not sufficient for transcriptional activation.
Wong J; Shi YB; Wolffe AP
EMBO J; 1997 Jun; 16(11):3158-71. PubMed ID: 9214633
[TBL] [Abstract][Full Text] [Related]
7. Nuclear receptors modulate the interaction of Sp1 and GC-rich DNA via ternary complex formation.
Husmann M; Dragneva Y; Romahn E; Jehnichen P
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):763-72. PubMed ID: 11104684
[TBL] [Abstract][Full Text] [Related]
8. Critical role of glutamine 252 in the hormone-dependent transcriptional activity of the thyroid hormone beta1 nuclear receptor.
Bhat MK; McPhie P; Cheng S
Biochemistry; 1997 Apr; 36(14):4233-9. PubMed ID: 9100018
[TBL] [Abstract][Full Text] [Related]
9. Heterodimeric receptor complexes determine 3,5,3'-triiodothyronine and retinoid signaling specificities.
Hermann T; Hoffmann B; Zhang XK; Tran P; Pfahl M
Mol Endocrinol; 1992 Jul; 6(7):1153-62. PubMed ID: 1324421
[TBL] [Abstract][Full Text] [Related]
10. Millisecond to microsecond time scale dynamics of the retinoid X and retinoic acid receptor DNA-binding domains and dimeric complex formation.
van Tilborg PJ; Mulder FA; de Backer MM; Nair M; van Heerde EC; Folkers G; van der Saag PT; Karimi-Nejad Y; Boelens R; Kaptein R
Biochemistry; 1999 Feb; 38(7):1951-6. PubMed ID: 10026278
[TBL] [Abstract][Full Text] [Related]
11. Hetero- and homodimeric receptors in thyroid hormone and vitamin A action.
Zhang XK; Pfahl M
Receptor; 1993; 3(3):183-91. PubMed ID: 8167569
[TBL] [Abstract][Full Text] [Related]
12. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
13. The retinoid X receptor binding to the thyroid hormone receptor: relationship with cofactor binding and transcriptional activity.
Tagami T; Yamamoto H; Moriyama K; Sawai K; Usui T; Shimatsu A; Naruse M
J Mol Endocrinol; 2009 May; 42(5):415-28. PubMed ID: 19211732
[TBL] [Abstract][Full Text] [Related]
14. A method for efficient production of recombinant thyroid hormone receptors reveals that receptor homodimer-DNA binding is enhanced by the coactivator TIF2.
Diallo EM; Thompson DL; Koenig RJ
Protein Expr Purif; 2005 Apr; 40(2):292-8. PubMed ID: 15766871
[TBL] [Abstract][Full Text] [Related]
15. Protein-protein interaction domains and the heterodimerization of thyroid hormone receptor variant alpha2 with retinoid X receptors.
Wu Y; Yang YZ; Koenig RJ
Mol Endocrinol; 1998 Oct; 12(10):1542-50. PubMed ID: 9773977
[TBL] [Abstract][Full Text] [Related]
16. Ligand-dependent degradation of retinoid X receptors does not require transcriptional activity or coactivator interactions.
Osburn DL; Shao G; Seidel HM; Schulman IG
Mol Cell Biol; 2001 Aug; 21(15):4909-18. PubMed ID: 11438648
[TBL] [Abstract][Full Text] [Related]
17. Ligand-triggered stabilization of vitamin D receptor/retinoid X receptor heterodimer conformations on DR4-type response elements.
Quack M; Carlberg C
J Mol Biol; 2000 Feb; 296(3):743-56. PubMed ID: 10677278
[TBL] [Abstract][Full Text] [Related]
18. Purification and properties of thyroid hormone receptor beta 1 expressed in Escherichia coli as a fusion protein.
Ball EH; Shephard LB; Gill GN
Protein Expr Purif; 1995 Feb; 6(1):33-8. PubMed ID: 7756836
[TBL] [Abstract][Full Text] [Related]
19. Thyroid hormone receptor-beta mutants associated with generalized resistance to thyroid hormone show defects in their ligand-sensitive repression function.
Piedrafita FJ; Ortiz MA; Pfahl M
Mol Endocrinol; 1995 Nov; 9(11):1533-48. PubMed ID: 8584031
[TBL] [Abstract][Full Text] [Related]
20. Half-site arrangement of hybrid glucocorticoid and thyroid hormone response elements specifies thyroid hormone receptor complex binding to DNA and transcriptional activity.
Yen PM; Ikeda M; Wilcox EC; Brubaker JH; Spanjaard RA; Sugawara A; Chin WW
J Biol Chem; 1994 Apr; 269(17):12704-9. PubMed ID: 8175681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
